Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-008544
Filing Date
2005-03-31
Accepted
2005-03-31 15:25:02
Documents
12
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2154779z10-k.htm 10-K 723511
2 EXHIBIT 23.1 a2154779zex-23_1.htm EX-23.1 2129
3 EXHIBIT 31.1 a2154779zex-31_1.htm EX-31.1 5991
4 EXHIBIT 31.2 a2154779zex-31_2.htm EX-31.2 5983
5 EXHIBIT 32 a2154779zex-32.htm EX-32 5890
6 G458482.JPG g458482.jpg GRAPHIC 68278
7 G432047.JPG g432047.jpg GRAPHIC 24394
8 G528599.JPG g528599.jpg GRAPHIC 33594
9 G67649.JPG g67649.jpg GRAPHIC 29371
10 G320297.JPG g320297.jpg GRAPHIC 27128
11 G900506.JPG g900506.jpg GRAPHIC 37886
12 G767216.JPG g767216.jpg GRAPHIC 22534
  Complete submission text file 0001047469-05-008544.txt   989263
Mailing Address
Business Address 9390 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
METABASIS THERAPEUTICS INC (Filer) CIK: 0001053221 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-50785 | Film No.: 05719789
SIC: 2834 Pharmaceutical Preparations